Novo Nordisk A/S (NYSE:NVO)
| 91.30 Delayed Data As of Sep 22 |  +0.01 / +0.01%Today’s Change | 47.51 Today|||52-Week Range 100.88 | +34.92% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 2 2018 | Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | |||
| Revenue and Income | Net Revenues | 4.4B | 4.3B | 4.5B | 4.5B | |
| Cost of Goods Sold | 573.0M | 566.6M | 460.4M | 558.9M | ||
| Depreciation And Amortization | 122.8M | 122.2M | 251.1M | 161.0M | ||
| Operating Expenses | Gross Income | 3.7B | 3.6B | 3.8B | 3.7B | |
| General Expenses | 1.8B | 1.8B | 2.2B | 1.6B | ||
| Research And Development | 527.0M | 568.5M | 694.9M | 407.4M | ||
| Total Operating Expenses | 2.5B | 2.5B | 2.9B | 2.3B | ||
| Non-Operating Expenses | Operating Income | 1.9B | 1.8B | 1.6B | 2.1B | |
| Interest Expense On Debt | 119.1M | 93.1M | 57.5M | 156.7M | ||
| Other Expenses | 61.7M | 14.4M | 31.8M | 32.7M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | 2.0B | 1.7B | 1.6B | 2.0B | |
| Income Taxes | -344.5M | -327.8M | -286.4M | -422.5M | ||
| Net Income | 1.7B | 1.4B | 1.3B | 1.6B | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 2.4B | 2.4B | 2.4B | 2.4B | |
| Shares To Calculate EPS Diluted | 2.4B | 2.4B | 2.4B | 2.4B | ||
| Earnings Per Share | EPS | $0.68 | $0.58 | $0.54 | $0.66 | |
| EPS Diluted | $0.68 | $0.58 | $0.54 | $0.66 | ||